Profil
Sarah Liu worked as Vice President-Global Marketing at Novartis Gene Therapies, Inc. and Vice President-Marketing at Melinta Therapeutics, Inc. She also served as Chief Commercial Officer at 9 Meters Biopharma, Inc. from 2022 to 2023.
Ms. Liu completed her undergraduate degree at Northwestern University and earned an MBA from The Wharton School of the University of Pennsylvania.
Anciens postes connus de Sarah Liu
| Sociétés | Poste | Fin |
|---|---|---|
| 9 METERS BIOPHARMA, INC. | Corporate Officer/Principal | 17/07/2023 |
| MELINTA THERAPEUTICS, INC. | Sales & Marketing | - |
| AVEXIS INC | Sales & Marketing | - |
Formation de Sarah Liu
| Northwestern University | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| 9 METERS BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
Melinta Therapeutics, Inc.
 Melinta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ. | Health Technology |
